Skip to main content
PFSA
NASDAQ Industrial Applications And Services

Profusa Seeks Votes to Convert 3.31M Preferred Shares and Widen Reverse Split to 1-for-200

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.52
Mkt Cap
$332.5K
52W Low
$0.51
52W High
$1,593.754
52W Position info
2.0% above low
Off High info
100% below high
Rel. Volume
Market data snapshot near publication time

PFSA is trading near its 52-week low of $0.51 (2.0% above the low).

Summary

Profusa's December 11 special meeting asks holders to approve converting Series A Preferred into 3,310,393 common shares and to authorize reverse splits up to 1-for-200. Approval completes the debt-for-equity cleanup; rejection triggers 90-day repeat meetings and a potential cash redemption.


Key Events · Corporate Governance and Compliance · PFSA

  • Vote Set on 3.31M Share Conversion

    At the special meeting on December 11, 2026, holders will vote on issuing 3,310,393 common shares upon conversion of Series A Preferred — 2,261,000 from the Exchange Agreements and 1,049,393 from the Subscription Agreements.

  • Dilution From Debt Reorganization

    The conversion retires roughly $9.9M of notes plus $4.49M of service-provider fees without cash, but existing holders end up with a far smaller slice of a company whose entire market value is about $333K.

  • Reverse Split Range Widened to 1-for-200

    The board would gain authority for splits from 1-for-2 up to an aggregate 1-for-200 through December 11, 2028, on top of the 1-for-2 to 1-for-12 authority already approved September 18, 2026 and not yet used.

  • Rejection Triggers Redemption Risk

    Without approval, the preferred stays unconverted, the company must hold a new shareholder meeting every 90 days, and after 18 months holders may force cash redemption at fair market value — which the company says it cannot fund.


Analysis · PFSA · Industrial Applications And Services

Profusa is asking shareholders on December 11 to approve two items that determine whether its August debt cleanup actually holds. The first is converting the Series A Preferred issued in the debt reorganization into 3,310,393 common shares; without approval, the preferred stays frozen, the company must re-run a shareholder meeting every 90 days, and after 18 months holders can demand cash redemption the company says it cannot fund. The second is a far broader reverse split authority (1-for-2 up to 1-for-200, versus the 1-for-12 already approved in September) so the board can keep the price above Nasdaq's $1.00 bid after that conversion floods the share count. Dilution is the real cost: 3.31M new shares against a company trading near its 52-week low, with the stock at $0.5203 and a market value of roughly $333K. Approval avoids a cash redemption and a delisting spiral; rejection leaves the balance sheet frozen and the listing at risk.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 47.7% of the 1624 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PFSA was trading at $0.52 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $332.5K. The 52-week trading range was $0.51 to $1,593.75. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Nov 06, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.530
Real-time Price: $0.5203 info
Change: -$0.0097 (-2%) info
Market Cap: $332.5K info
PFSA
Oct 15, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.26
Real-time Price: $0.5203 info
Change: -$0.7397 (-59%) info
Market Cap: $332.5K info
PFSA
Oct 09, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.41
Real-time Price: $0.5203 info
Change: -$0.8897 (-63%) info
Market Cap: $332.5K info
PFSA
Oct 05, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.74
Real-time Price: $0.5203 info
Change: -$1.22 (-70%) info
Market Cap: $332.5K info
PFSA
Sep 24, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $0.5203 info
Change: -$2.29 (-81%) info
Market Cap: $332.5K info